ID   DLKP-A5F
AC   CVCL_H743
DR   Wikidata; Q54831180
RX   PubMed=9180164;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H741 ! DLKP-A
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
RX   PubMed=9180164; DOI=10.1002/(SICI)1097-0215(19970529)71:5<907::AID-IJC33>3.0.CO;2-1;
RA   Heenan M., O'Driscoll L., Cleary I., Connolly L., Clynes M.;
RT   "Isolation from a human MDR lung cell line of multiple clonal
RT   subpopulations which exhibit significantly different drug
RT   resistance.";
RL   Int. J. Cancer 71:907-915(1997).
//
RX   PubMed=19242932; DOI=10.1002/pmic.200800633;
RA   Keenan J., Murphy L., Henry M., Meleady P., Clynes M.;
RT   "Proteomic analysis of multidrug-resistance mechanisms in
RT   adriamycin-resistant variants of DLKP, a squamous lung cancer cell
RT   line.";
RL   Proteomics 9:1556-1566(2009).
//